Sign in

CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822844431
Phone
484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-12-07 Javitt Jonathan C Director Sale −400,000 $1.00 $400K 12,899,997
2022-11-30 Javitt Daniel C. 10% owner Sale −8,441 $1.50 $13K 9,634,793
2022-11-29 Javitt Daniel C. 10% owner Sale −13,730 $1.50 $21K 9,643,234
2022-11-17 Javitt Daniel C. 10% owner Sale −33,018 $1.05 $35K 9,656,964
2022-11-16 Javitt Daniel C. 10% owner Sale −133,719 $1.02 $136K 9,689,982
2022-11-11 Javitt Daniel C. 10% owner Sale −49,200 $1.01 $50K 9,823,701
2022-07-29 Javitt Daniel C. 10% owner Sale −784,063 $1.01 $791K 9,872,901
2022-06-07 Javitt Daniel C. 10% owner Sale −86,459 $0.65 $56K 12,656,964
2022-06-06 Javitt Daniel C. 10% owner Sale −115,657 $0.67 $77K 12,743,423
2022-06-03 Javitt Daniel C. 10% owner Sale −243,596 $0.70 $171K 12,859,080
2021-09-15 Besthof Robert Chief Comm. & Patient Officer Sale −40,000 $11.76 $470K 23,710
2021-08-23 Daigneault Alessandra General Counsel & Secretary Sale −33,715 $13.11 $442K 0
2020-03-13 Polar Asset Management Partners Inc. 10% owner Sale −29,464 $10.60 $312K 488,036
2018-11-20 ACKERMAN RICHARD President and CEO Sale −1,500,000 225,000

Page 1 of 1 · 14 trades